[Federal Register: July 17, 2002 (Volume 67, Number 137)]

[Proposed Rules]

[Page 46949-46950]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]





Centers for Medicare & Medicaid Services

42 CFR Chapter IV


RIN 0938-ZA40


The Senate yesterday (July 17) backed a legislative proposal by Sen. Byron Dorgan (D-ND), as amended by Sen. Thad Cochran (R-MS) requiring HHS certification, to allow parties other than drug manufacturers to reimport Rx drugs from Canada. Dorgan Amendment Cochran Amendment


Statement by Alan F. Holmer, President of the Pharmaceutical Research and Manufacturers of America (PhRMA), on the Senate Vote on Reimportation


July 12, 2002

Jo Anne B. Barnhart


Social Security Administration

6401 Security Blvd.

Baltimore, MD 21235

Tom Scully


Centers for Medicare and Medicaid Services

200 Independence Avenue, NW

Southwest Room 314-G

Washington, DC 20201

Dear Tom and Ms. Barnhart:



VIA FACSIMILE (202) 224-2126

The Honorable Senator Daniel K. Akaka

United States Senate

141 Hart Senate Office Building

Washington, DC 20510-1103

Re: Medicare Prescription Drug Benefit

Dear Senator Akaka:

As you engage in debate on a Medicare prescription drug benefit, I am writing to you to bring your attention to a group of people who have been overlooked so far in the discussion -- the nation's frail elderly who reside in nursing homes.

Governors Support the Secretary of Health and Human Services in Lawsuit over Preferred Drug Lists


Coalition for Access to Medical Services, Equipment and Technology (CAMSET)

News Release: July 17, 2002


Contact: Julie Phillips, Director of Communications

Phone: 703-535-1889

Email: juliep@protectaccess.org

Report Warns of Complex New Bureaucracy If Congress Passes National Medicare Competitive Bidding Program

July 17, 2002

Dear Senator:

On behalf of older people and people with disabilities represented by the undersigned organizations, we urge you not to support H.R. 2729, The 21st Century Medicare Act. The proposal fails to provide needed prescription drug relief to older persons and persons with disabilities and contains radical restructuring measures that weaken the traditional Medicare program. Fatal flaws in the bill include the following:


Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.